Doctor Amanda Cox

Dr Cox is a Senior Research Fellow at the Menzies Health Institute QLD. She has spent the last 15 years pursuing clinical translation research applying a holistic experimental approach to understand risk factors for disease and evaluate relevant intervention approaches. Her research contributions include one of the earliest probiotic supplementation studies in high performing athletes, seminal studies demonstrating utility of calcified plaque in predicting adverse outcome in diabetes-affected individuals and more recently development of phenotypic risk scoring approach using measures of intestinal permeability in assessing association with type 2 diabetes. Since joining MHIQ in 2013, Dr Cox’s research has focused on the various roles of the gut in obesity-associated inflammation and risk for metabolic disease, including compositional profiles of the gut microbiota in metabolic disease, microbial metabolites as a source of energy and cross-talk between inflammatory and insulin-signalling pathways.